13 unknown. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Unknown 13 |
Follow Neuroectodermal Tumors: new trials by email Literature Review of Neuroectodermal Tumors trials Research Report on Neuroectodermal Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sentinel Lymph Node Detection in Patients With Stage Ib-III Melanoma Using MSOT and ICG MSOT - Melanoma, Stage I, Melanoma, Stage II | Phase 4 | Unknown | University Medical Center Groningen | 10 | 2022-09-01 | 2022-07-20 |
| The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab Pembrolizumab - Newly Diagnosed Glioblastoma | Phase 4 | Unknown | Medical University of Silesia | 36 | 2022-03-01 | 2023-08-31 |
| Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response Nivolumab - Melanoma | Phase 4 | Unknown | Erasmus Medical Center | 34 | 2022-01-05 | 2024-04-22 |
| Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer Lymphoseek, Nanocoll - Head Cancer, Neck Cancer | Phase 4 | Unknown | Anna Cruceta | 30 | 2020-03-01 | 2020-02-20 |
| Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1 Nivolumab, MRI, BLOOD SAMPLES - Melanoma, Non-small Cell | Phase 4 | Unknown | Assistance Publique Hopitaux De Marseille | 50 | 2018-04-09 | 2023-04-21 |
| Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET Lanreotide - Neuroendocrine Tumors | Phase 4 | Unknown | Samsung Medical Center | 28 | 2017-07-05 | 2019-05-20 |
| G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor GM-CSF, G-CSF, GM-CSF and G-CSF - Acute Myeloid Leukemia, Acute Lymphoid Leukemia | Phase 4 | Unknown | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 405 | 2016-09-27 | 2018-10-17 |
| Nonfunctional Pancreatic NET and PET Imaging PET/CT - Diagnosis | Phase 4 | Unknown | Turku University Hospital | 20 | 2015-12-01 | 2016-01-06 |
| TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy Triamcinolone Acetonide, Transpupillary thermotherapy - Exudative Retinal Detachment, Uveal Melanoma | Phase 4 | Unknown | Charite University, Berlin, Germany | 50 | 2015-01-01 | 2017-02-08 |
| Radiolabeled Molecules for Medullary Thyroid Cancer Lu 177 - Medullary Thyroid Cancer | Phase 4 | Unknown | Instituto Nacional de Cancer, Brazil | 20 | 2013-08-01 | 2016-09-07 |
| Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions Hydrocortisone, Prednisone - Pituitary Neoplasms, Craniopharyngiomas | Phase 4 | Unknown | West China Hospital | 100 | 2013-08-01 | 2014-07-15 |
| Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy Ranibizumab - Uveal Melanoma, Radiation Retinopathy | Phase 4 | Unknown | Shields, Shields and Associates | 400 | 2007-04-01 | 2007-10-08 |
| Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma Cisplatin, Vindesine, Dacarbazine (drugs) - Metastatic Melanoma | Phase 4 | Unknown | Dermatologic Cooperative Oncology Group | 200 | 2001-09-01 | 2006-06-21 |
Melanoma (5) · Neuroendocrine Tumors (2) · Uveal Melanoma (2) · Breast Neoplasms (1) · Carcinoma, Medullary (1) · Craniopharyngioma (1) · Disease (1) · Glioblastoma (1) · Head and Neck Neoplasms (1) · Hepatoblastoma (1) · Leukemia, Myeloid, Acute (1) · Lung Neoplasms (1) · Lymphoma (1) · Neoplasm Metastasis (1) · Neuroblastoma (1)
Neoplasms (13) · Neoplasms by Histologic Type (13) · Neoplasms, Germ Cell and Embryonal (13) · Neoplasms, Nerve Tissue (13) · Neoplasms by Site (9) · Neuroendocrine Tumors (8) · Nevi and Melanomas (7) · Skin Diseases (5) · Skin Neoplasms (5) · Skin and Connective Tissue Diseases (5) · Eye Diseases (3) · Eye Neoplasms (3) · Neoplasms, Glandular and Epithelial (3) · Melanoma (2)
Nivolumab (2) · Blood Specimen Collection (1) · Cisplatin (1) · Dacarbazine (1) · Granulocyte Colony-Stimulating Factor (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1) · Hydrocortisone (1) · Lutetium-177 (1) · Pharmaceutical Preparations (1) · Positron Emission Tomography Computed Tomography (1) · Prednisone (1) · Ranibizumab (1) · Triamcinolone Acetonide (1) · Vindesine (1) · lanreotide (1)
Anna Cruceta (1) · Assistance Publique Hopitaux De Marseille (1) · Charite University, Berlin, Germany (1) · Dermatologic Cooperative Oncology Group (1) · Erasmus Medical Center (1) · Instituto Nacional de Cancer, Brazil (1) · Medical University of Silesia (1) · Samsung Medical Center (1) · Shields, Shields and Associates (1) · Turku University Hospital (1) · University Medical Center Groningen (1) · West China Hospital (1) · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)
China (2) · Germany (2) · Brazil (1) · Finland (1) · France (1) · Netherlands (1) · Poland (1) · South Korea (1) · Spain (1) · United States (1)
Axel Hauschild, MD (1) · Carol L Shields, MD (1) · Fang Yongjun, Ph.D (1) · Fernanda Vaisman, MD, PhD (1) · Gao Fei, Ph.D (1) · Hu Shaoyan, Ph.D (1) · Ira Seibel, MD (1) · Jens Ulrich, MD (1) · Li Aimin, Ph.D (1) · Liang Changda, Master (1) · Liu Wei, Ph.D (1) · Pan Kaili, Master (1) · Peter Mohr, MD (1) · Saila Kauhanen, MD, PhD (1)
2017 (1), 2019 (1)